MUSL — Promino Nutritional Sciences Income Statement
0.000.00%
Consumer DefensivesSpeculativeMicro Cap
Annual income statement for Promino Nutritional Sciences, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.979 | 2.36 | 4 | 0.478 | 0.261 |
Cost of Revenue | |||||
Gross Profit | 0.163 | 0.175 | -0.508 | 0.256 | -0.343 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8.64 | 12.4 | 14.4 | 5.55 | 7.25 |
Operating Profit | -7.66 | -10.1 | -10.4 | -5.07 | -6.99 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.72 | -8.78 | -10.3 | -5.81 | -7.41 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.72 | -8.78 | -10.3 | -5.81 | -7.41 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.72 | -8.78 | -10.3 | -5.81 | -7.41 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.72 | -8.78 | -10.3 | -5.81 | -7.41 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.04 | -0.101 | -0.091 | -0.125 | -0.094 |